Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Jett

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatinH Takahashi, Y Sasaki, N Saijo, et al.
The American Journal of Surgical Pathology|January 15, 1999
Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung diseaseA J Egan, L A Boardman, H D Tazelaar, et al.
Investigational New Drugs|January 1, 1987
The colony inhibition of a new chemotherapeutic agent (KW2152) against human lung cancer cell linesJ R Jett, N Saijo, W S Hong, et al.
Nature|April 10, 1980
A new immunodeficiency disorder in humans involving NK cellsJ C Roder, T Haliotis, M Klein, et al.
American Journal of Clinical Oncology|April 1, 1996
Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancerS Frytak, E G Shaw, J R Jett, et al.
American Journal of Clinical Oncology|February 1, 1989
Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiationS Frytak, J N Shaw, B P O'Neill, et al.
Cancer|February 15, 1994
Phase II trial of edatrexate in small cell lung cancerM Wiesenfeld, J R Jett, J Q Su, et al.
Cancer Investigation|January 1, 1988
Treatment toxicities in long-term survivors of limited small cell lung cancerS Frytak, J N Shaw, R E Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2005
A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG studyG K Dy, A A Miller, S J Mandrekar, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatinH Takahashi, Y Sasaki, N Saijo, et al.
The American Journal of Surgical Pathology|January 15, 1999
Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung diseaseA J Egan, L A Boardman, H D Tazelaar, et al.
Investigational New Drugs|January 1, 1987
The colony inhibition of a new chemotherapeutic agent (KW2152) against human lung cancer cell linesJ R Jett, N Saijo, W S Hong, et al.
Nature|April 10, 1980
A new immunodeficiency disorder in humans involving NK cellsJ C Roder, T Haliotis, M Klein, et al.
American Journal of Clinical Oncology|April 1, 1996
Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancerS Frytak, E G Shaw, J R Jett, et al.
American Journal of Clinical Oncology|February 1, 1989
Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiationS Frytak, J N Shaw, B P O'Neill, et al.
Cancer|February 15, 1994
Phase II trial of edatrexate in small cell lung cancerM Wiesenfeld, J R Jett, J Q Su, et al.
Cancer Investigation|January 1, 1988
Treatment toxicities in long-term survivors of limited small cell lung cancerS Frytak, J N Shaw, R E Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2005
A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG studyG K Dy, A A Miller, S J Mandrekar, et al.
Pageof 8